Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression

Cytokine

Volumn 58, Issue 3, 2012, Pages 437-447

  Illi, Julie ^a   Miaskowski, Christine ^a   Cooper, Bruce ^a   Levine, Jon D ^a,b   Dunn, Laura ^b   West, Claudia ^a   Dodd, Marylin ^a   Dhruva, Anand ^b   Paul, Steven M ^a   Baggott, Christina ^a   Cataldo, Janine ^a   Langford, Dale ^a   Schmidt, Brian ^c   Aouizerat, Bradley E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Cytokines; Depression; Fatigue; Pain; Sleep disturbance

Indexed keywords

ADULT; AGE; ALLELE; ANALYTIC METHOD; ARTICLE; CANCER FATIGUE; CANCER PAIN; CANCER PATIENT; CAREGIVER BURDEN; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FUNCTIONAL STATUS; GENE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL4 GENE; IL8 GENE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; SYMPTOMATOLOGY;

AGED; CYTOKINES; DEPRESSION; FATIGUE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SLEEP DISORDERS;

EID: 84860327799     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.02.015     Document Type: Article

References (92)

1. Fletcher B.A., Miaskowski C., Dodd M.J., Schumacher K.L. A review of the literature on the symptom experience of family caregivers of patients with cancer. Oncol Nurs Forum 2008, 35:E23-E44.
2. Fletcher B.A., Schumacher K.L., Dodd M., Paul S.M., Cooper B.A., Lee K., et al. Trajectories of fatigue in family caregivers of patients undergoing radiation therapy for prostate cancer. Res Nurs Health 2009, 32:125-139.
3. Fletcher B.S., Paul S.M., Dodd M.J., Schumacher K., West C., Cooper B., et al. Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol 2008, 26:599-605.
4. Gibbins J., McCoubrie R., Kendrick A.H., Senior-Smith G., Davies A.N., Hanks G.W. Sleep-wake disturbances in patients with advanced cancer and their family carers. J Pain Symptom Manage 2009, 38:860-870.
5. Carney S., Koetters T., Cho M., West C., Paul S.M., Dunn L., et al. Differences in sleep disturbance parameters between oncology outpatients and their family caregivers. J Clin Oncol 2011, 29:1001-1006.
6. Barsevick A.M. The concept of symptom cluster. Semin Oncol Nurs 2007, 23:89-98.
7. Barsevick A.M. The elusive concept of the symptom cluster. Oncol Nurs Forum 2007, 34:971-980.
8. Chen M.L., Tseng H.C. Symptom clusters in cancer patients. Support Care Cancer 2006, 14:825-830.
9. Dodd M.J., Miaskowski C., Paul S.M. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001, 28:465-470.
10. Miaskowski C., Aouizerat B.E. Is there a biological basis for the clustering of symptoms?. Semin Oncol Nurs 2007, 23:99-105.
11. Miaskowski C., Aouizerat B.E., Dodd M., Cooper B. Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. J Natl Cancer Inst Monogr 2007, 37:39-46.
12. Miaskowski C., Dodd M., Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 2004, 17-21.
13. Desai M.J., Kim A., Fall P.C., Wang D. Optimizing quality of life through palliative care. J Am Osteopath Assoc 2007, 107:ES9-ES14.
14. Dodd M.J., Cho M.H., Cooper B.A., Petersen J., Bank K.A., Lee K.A., et al. Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncol Nurs Forum 2011, 38:33-42.
15. Esther Kim J.E., Dodd M.J., Aouizerat B.E., Jahan T., Miaskowski C. A review of the prevalence and impact of multiple symptoms in oncology patients. J Pain Symptom Manage 2009, 37:715-736.
16. Granda-Cameron C., Viola S.R., Lynch M.P., Polomano R.C. Measuring patient- oriented outcomes in palliative care: functionality and quality of life. Clin J Oncol Nurs 2008, 12:65-77.
17. Gwede C.K., Small B.J., Munster P.N., Andrykowski M.A., Jacobsen P.B. Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach. Support Care Cancer 2008, 16:925-933.
18. Dodd M.J., Cho M.H., Cooper B.A., Miaskowski C. The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs 2010, 14:101-110.
19. Pud D., Ben Ami S., Cooper B.A., Aouizerat B.E., Cohen D., Radiano R., et al. The symptom experience of oncology outpatients has a different impact on quality-of- life outcomes. J Pain Symptom Manage 2008, 35:162-170.
20. Miaskowski C., Cooper B.A., Paul S.M., Dodd M., Lee K., Aouizerat B.E., et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 2006, 33:E79-E89.
21. Cleeland C.S., Bennett G.J., Dantzer R., Dougherty P.M., Dunn A.J., Meyers C.A., et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003, 97:2919-2925.
22. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007, 21:153-160.
23. Dantzer R., Bluthe R.M., Gheusi G., Cremona S., Laye S., Parnet P., et al. Molecular basis of sickness behavior. Ann NY Acad Sci 1998, 856:132-138.
24. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav Immun 2001, 15:7-24.
25. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002, 25:154-159.
26. Watkins L.R., Maier S.F., Goehler L.E. Immune activation: the role of pro- inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995, 63:289-302.
27. Watkins L.R., Maier S.F. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000, 51:29-57.
28. Krabbe K.S., Reichenberg A., Yirmiya R., Smed A., Pedersen B.K., Bruunsgaard H. Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 2005, 19:453-460.
29. Eisenberger N.I., Berkman E.T., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 2010, 68:748-754.
30. Brydon L., Walker C., Wawrzyniak A., Whitehead D., Okamura H., Yajima J., et al. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun 2009, 23:217-224.
31. Seruga B., Zhang H., Bernstein L.J., Tannock I.F. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 2008, 8:887-899.
32. Maier S.F., Watkins L.R. Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain Behav Immun 2003, 17(Suppl. 1):S125-S131.
33. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 2001, 21:5027-5035.
34. Uceyler N., Rogausch J.P., Toyka K.V., Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology 2007, 69:42-49.
35. Lu C.H., Chao P.C., Borel C.O., Yang C.P., Yeh C.C., Wong C.S., et al. Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery. Anesth Analg 2004, 99:1465-1471.
36. Schubert C., Hong S., Natarajan L., Mills P.J., Dimsdale J.E. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007, 21:413-427.
37. Rich T., Innominato P.F., Boerner J., Mormont M.C., Iacobelli S., Baron B., et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005, 11:1757-1764.
38. Aouizerat B.E., Dodd M., Lee K., West C., Paul S.M., Cooper B.A., et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 2009, 11:27-41.
39. Miaskowski C., Dodd M., Lee K., West C., Paul S.M., Cooper B.A., et al. Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. J Pain Symptom Manage 2010, 40:531-544.
40. Collado-Hidalgo A., Bower J.E., Ganz P.A., Irwin M.R., Cole S.W. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav Immun 2008, 22:1197-1200.
41. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005, 90:2522-2530.
42. Brambilla F., Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 1998, 97:309-313.
43. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. A meta- analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
44. Kiecolt-Glaser J.K., Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002, 53:873-876.
45. Lutgendorf S.K., Garand L., Buckwalter K.C., Reimer T.T., Hong S.Y., Lubaroff D.M. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci 1999, 54:M434-M439.
46. Maes M., Bosmans E., Meltzer H.Y. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 1995, 245:172-178.
47. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997, 9:853-858.
48. Capuron L., Ravaud A., Miller A.H., Dantzer R. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun 2004, 18:205-213.
49. De La Garza R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev 2005, 29:761-770.
50. Reyes-Gibby C.C., Wu X., Spitz M., Kurzrock R., Fisch M., Bruera E., et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008, 9:777-785.
51. Daut R.L., Cleeland C.S., Flanery R.C. Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain 1983, 17:197-210.
52. Jensen M.P. The validity and reliability of pain measures in adults with cancer. J Pain 2003, 4:2-21.
53. Lee K.A., Hicks G., Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 1991, 36:291-298.
54. Gay C.L., Lee K.A., Lee S.Y. Sleep patterns and fatigue in new mothers and fathers. Biol Res Nurs 2004, 5:311-318.
55. Lee K.A., Portillo C.J., Miramontes H. The fatigue experience for women with human immunodeficiency virus. J Obstet Gynecol Neonatal Nurs 1999, 28:193-200.
56. Miaskowski C., Lee K.A. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 1999, 17:320-332.
57. Miaskowski C., Paul S.M., Cooper B.A., Lee K., Dodd M., West C., et al. Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. J Pain Symptom Manage 2008, 35:632-643.
58. Barsevick A., Beck S.L., Dudley W.N., Wong B., Berger A.M., Whitmer K., et al. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage 2010, 40:200-216.
59. Lee K.A. Self-reported sleep disturbances in employed women. Sleep 1992, 15:493-498.
60. Lee K.A., DeJoseph J.F. Sleep disturbances, vitality, and fatigue among a select group of employed childbearing women. Birth 1992, 19:208-213.
61. Carpenter J.S., Andrykowski M.A., Wilson J., Hall L.A., Rayens M.K., Sachs B., et al. Psychometrics for two short forms of the Center for Epidemiologic Studies- Depression Scale. Issues Ment Health Nurs 1998, 19:481-494.
62. Radloff L.S. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
63. Sheehan T.J., Fifield J., Reisine S., Tennen H. The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess 1995, 64:507-521.
64. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
65. Muthen B., Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics 1999, 55:463-469.
66. Vermunt J.K., Magdison J. Latent class cluster analyses 2002, Cambridge University Press, New York.
67. Everitt B.S., Landau S., Leese M. Cluster analysis 2001, Oxford University Press, New York. 4th ed.
68. Collins L.M., Lanza S.T. Latent class and latent transition analysis: with applications in the social, behavioral, and health science 2010, John Wiley & Sons, Hoboken, NJ.
69. Nylund K., Bellmore A., Nishina A., Graham S. Subtypes, severity, and structural stability of peer victimization: what does latent class analysis say?. Child Dev 2007, 78:1706-1722.
70. Nylund K.L., Asparouhov T., Muthen B.O. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling 2007, 14:535-569.
71. Celeux G., Soromenho G. An entropy criterion for assessing the number of clusters in a mixture model. J Classif 1996, 13:195-212.
72. Collins L.M., Wugalter S.E. Latent class models for stage-sequential dynamic latent variables. Multivar Behav Res 1992, 27:131-157.
73. Lanza S.T., Flaherty B.P., Collins L.M. Latent class and latent transition analysis. Handbook of psychology: research methods in psychology 2003, 663-685. John Wiley & Sons, Inc., Hoboken, NJ. J.A. Schinka, W.F. Velicer (Eds.).
74. Olsen M.K., Schafer J.L. A two-part random effects model for semicontinuous longitudinal data. J Am Stat Assoc 2001, 96:730-745.
75. Muthen L.K., Muthen B.O. Mplus user's guide 1998-2010, Muthen & Muthen, Los Angeles, CA. 6th ed.
76. Muthen L.K., Muthen B.O. Mplus 1998-2010, Muthen & Muthen, Los Angeles, CA. 6th ed.
77. SPSS IBM SPSS for Windows (version 19) 2010, SPSS, Inc., Chicago, Illinois.
78. Dantzer R., Capuron L., Irwin M.R., Miller A.H., Ollat H., Perry V.H., et al. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008, 33:18-29.
79. Conde L., Vaquerizas J.M., Dopazo H., Arbiza L., Reumers J., Rousseau F., et al. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res 2006, 34:W621-W625.
80. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
81. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
82. Hoggart C.J., Parra E.J., Shriver M.D., Bonilla C., Kittles R.A., Clayton D.G., et al. Control of confounding of genetic associations in stratified populations. Am J Hum Genet 2003, 72:1492-1504.
83. Halder I., Shriver M., Thomas M., Fernandez J.R., Frudakis T. A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Hum Mutat 2008, 29:648-658.
84. Tian C., Gregersen P.K., Seldin M.F. Accounting for ancestry: population substructure and genome-wide association studies. Hum Mol Genet 2008, 17:R143-R150.
85. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909.
86. Hamblin A. Cytokines and cytokine receptors 1993, Oxford University Press, New York. 2nd ed.
87. Parnet P., Kelley K.W., Bluthe R.M., Dantzer R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J Neuroimmunol 2002, 125:5-14.
88. Lyons A., McQuillan K., Deighan B.F., O'Reilly J.A., Downer E.J., Murphy A.C., et al. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Behav Immun 2009, 23:1020-1027.
89. Sherry C.L., Kim S.S., Dilger R.N., Bauer L.L., Moon M.L., Tapping R.I., et al. Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization. Brain Behav Immun 2010, 24:631-640.
90. Carlson L.E., Speca M., Patel K.D., Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003, 65:571-581.
91. Tizard I. Sickness behavior, its mechanisms and significance. Anim Health Res Rev 2008, 9:87-99.
92. Myers J.S. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. Oncol Nurs Forum 2008, 35:802-807.